Does the etiology of cardiac amyloidosis determine the myocardial uptake of [18F]-NaF PET/CT?

Rapezzi, 2009, Systemic cardiac amyloidoses: Disease profiles and clinical courses of the 3 main types, Circulation, 120, 1203, 10.1161/CIRCULATIONAHA.108.843334

Rapezzi, 2011, Usefulness and limitations of 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathy, Eur J Nucl Med Mol Imaging, 38, 470, 10.1007/s00259-010-1642-7

Van Der Gucht, 2015, [18F]-NaF PET/CT imaging in cardiac amyloidosis, J Nucl Cardiol